It’s time to explore divergent dementia trends in the UK and Japan to inform policies to reduce dementia risk
Can cultural differences also affect the risk of developing dementia? If so, there could be important policy implications. Dr Dorina Cadar is part of an international team of researchers doing cross-country comparative with UK and Japanese cohorts.
The English Longitudinal Study of Ageing is a representative cohort of the English population in the DPUK Data Portal – it has unique data with some real potential for cross-cohort dementia research. 2002 is the year it got started, 18,000 is the number of participants, eight is the number of times they have done medical tests, and 65 is their average age now. If you are interested in dementia research and have not considered using this valuable health study yet, Dorina Cader explains why you should.
Cohorts Researchers Stem cells
Bryan spends a lot of time in a lab, nose down a microscope just like many of his colleagues from university. But the special cells he’s working with put him right at the frontier of cell-based studies in dementia. He’s working with patient-specific stem cells which will enable him to compare the experimental outcomes he’s observing with symptoms which were recorded in the clinics.
Cohorts General Impact Public Researchers Trials
Ivan Koychev, Great Minds lead and Clinical Scientist at Dementias Platform UK (DPUK), describes an exciting new chapter in dementia research which, with the support of generous new members of Great Minds, promises to accelerate the development of innovative new treatments.
‘I’d thought it was all doom and gloom for dementia research,’ said Marianne. ‘But I’d not understood that sometimes this is because testing on volunteers only takes place too late.’ DPUK brought together study participant Marianne Talbot and old-age psychiatrist Dr Ivan Koychev to discuss the bright prospects cohort studies offer dementia research.